‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
The Beacon
New Target & Treatment in Advanced NSCLC: Dabrafenib/Trametinib for BRAF V600E Mutation-Positive NSCLC (BMIC-018)
30
00:00:00
/ 00:06:25
30